Vis enkel innførsel

dc.contributor.authorSarkar, Aurijiten_US
dc.contributor.authorBrenk, Ruthen_US
dc.date.accessioned2016-04-12T12:23:08Z
dc.date.available2016-04-12T12:23:08Z
dc.date.issued2015-09-11
dc.PublishedPLoS ONE 2015, 19:e0137279(9)eng
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/1956/11897
dc.description.abstractPseudomonas aeruginosa is a Gram-negative bacterium known to cause opportunistic infections in immune-compromised or immunosuppressed individuals that often prove fatal. New drugs to combat this organism are therefore sought after. To this end, we subjected the gene products of predicted perturbative genes to structure-based druggability predictions using DrugPred. Making this approach suitable for large-scale predictions required the introduction of new methods for calculation of descriptors, development of a workflow to identify suitable pockets in homologous proteins and establishment of criteria to obtain valid druggability predictions based on homologs. We were able to identify 29 perturbative proteins of P. aeruginosa that may contain druggable pockets, including some of them with no or no drug-like inhibitors deposited in ChEMBL. These proteins form promising novel targets for drug discovery against P. aeruginosa.en_US
dc.language.isoengeng
dc.publisherPloseng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/eng
dc.titleTo hit or not to hit, that is the question -genome-wide structure-based druggability predictions for pseudomonas aeruginosa proteinsen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2016-03-08T11:15:11Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2015 the authors
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0137279
dc.identifier.cristin1332480


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY